The functions of PP2A as a tumor suppressor in human cancers was originally defined as a result of its functional inactivation by the direct binding of the transforming antigens of the SV40 polyoma virus, as well as inactivating deletions and mutations of genes encoding its enzymatic subunits (3). This evidence concerns the gene PTPA and cancer.